Sigma Solve Limited — Others, 14-11-2024: Statement of deviation(s) or variation(s) under Reg. 32

Sigma Solve Limited has announced a board meeting to review the statement of deviations in the use of IPO proceeds for the quarter and half-year ended September 30, 2024. The company has decided to repurpose an unutilized amount of ₹31.57 crore from public issue expenses to general corporate purposes, in alignment with shareholder approval received in September 2022. There has been no change in the previously utilized amount of ₹265.45 crore.

This update may suggest increased flexibility in fund deployment, potentially enhancing operational efficiency and shareholder value. Investors may view this move positively, indicating proactive management of capital.